PDCD1 and neoplasm: Although direct cytotoxicity in vitro was not markedly increased by the addition of FilC and/or PD-1 inhibitor genes, these constructs conferred superior therapeutic effects in vivo, as evidenced by enhanced tumor regression and immune infiltration.